Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Authors’ Reply
BRIDGING THE GAP
BRIEF COMMUNICATION
BRIEF REPORT
Case Report
Case Reports
Case Series
CME
CME ARTICLE
CME articles - Practice points
COMMENTARY
CONFERENCE REPORT
Consensus Statement
CONTROVERSY
Correspondence
Correspondences
CUTANEOUS PATHOLOGY
DRUG REVIEW
E-CHAT
Editorial
EDITORIAL COMMENTARY
ERRATUM
ETHICAL HOTLINE
ETHICS
Field: Evolution of dermatologic surgergy
FOCUS
FROM THE ARCHIVES OF INDIAN JOURNAL OF DERMATO SURGERY
From the Editor's Desk
FROM THE LITERATURE
GUEST EDITORIAL
Guidelines
Image
Images in Clinical Practice
Images in Dermatosurgery
INNOVATION
Innovations
INVITED COMMENTARY
JCAS Symposium
LETTER
Letter to Editor
Letter to the Editor
LETTERS
Media & News
Message from the President
NEW HORIZON
Original Article
Point of View
Practice Point
Practice Points
PRESIDENTIAL SPEECH
QUIZ
RESEARCH ARTICLE
Resident’s Page
Review
Review Article
Review Articles
SHORT COMMUNICATION
Spot the Diagnosis [Quiz]
STUDY
SURGICAL PEARL
SYMPOSIUM
Symposium—Lasers
Symposium: Hair in Dermatology
Symposium: Lasers Review Article
View Point
VIEWPOINT
VIEWPOINTS
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Authors’ Reply
BRIDGING THE GAP
BRIEF COMMUNICATION
BRIEF REPORT
Case Report
Case Reports
Case Series
CME
CME ARTICLE
CME articles - Practice points
COMMENTARY
CONFERENCE REPORT
Consensus Statement
CONTROVERSY
Correspondence
Correspondences
CUTANEOUS PATHOLOGY
DRUG REVIEW
E-CHAT
Editorial
EDITORIAL COMMENTARY
ERRATUM
ETHICAL HOTLINE
ETHICS
Field: Evolution of dermatologic surgergy
FOCUS
FROM THE ARCHIVES OF INDIAN JOURNAL OF DERMATO SURGERY
From the Editor's Desk
FROM THE LITERATURE
GUEST EDITORIAL
Guidelines
Image
Images in Clinical Practice
Images in Dermatosurgery
INNOVATION
Innovations
INVITED COMMENTARY
JCAS Symposium
LETTER
Letter to Editor
Letter to the Editor
LETTERS
Media & News
Message from the President
NEW HORIZON
Original Article
Point of View
Practice Point
Practice Points
PRESIDENTIAL SPEECH
QUIZ
RESEARCH ARTICLE
Resident’s Page
Review
Review Article
Review Articles
SHORT COMMUNICATION
Spot the Diagnosis [Quiz]
STUDY
SURGICAL PEARL
SYMPOSIUM
Symposium—Lasers
Symposium: Hair in Dermatology
Symposium: Lasers Review Article
View Point
VIEWPOINT
VIEWPOINTS
View/Download PDF

Translate this page into:

Point of View
ARTICLE IN PRESS
doi:
10.25259/JCAS_7_2025

Creams and lotions or risky potions? The dangers of endocrine-disrupting chemicals

Department of Dermatology, Skin Konnect, Delhi, India
Department of Dermatology, Venereology and Leprosy, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala-Haryana, India.

*Corresponding author: Sanjeev Gupta, MM Institute of Medical Sciences and Research, MMDU, Mullana-Ambala, Haryana, India. sanjeevguptadr@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Gupta S, Gupta S, Dabhra A. Creams and lotions or risky potions? The dangers of endocrine-disrupting chemicals. J Cutan Aesthet Surg. doi: 10.25259/JCAS_7_2025

Abstract

Over the past few decades, our lifestyle has considerably changed. We have inadvertently loaded the environment with a myriad of chemicals, many of which have proven to have far-reaching consequences on our health. One such example is that of Endocrine Disruptors or Endocrine-Disrupting Chemicals, which may mimic or interfere with our body’s endocrine system. This article explains the deleterious effects of these chemicals on our body and focuses on which chemicals to avoid in moisturizers.

Keywords

Endocrine-disrupting chemicals
Harmful effects
Side effects
Topical agents
Xenoestrogens

INTRODUCTION

Endocrine-Disrupting Chemicals (EDCs) or endocrine disruptors are chemical agents that may mimic or interfere with the body’s endocrine system. EDCs are present in many everyday products. Cosmetics and personal care products often contain parabens, phthalates, and synthetic fragrances that may act as EDCs. Moisturizers and lotions can have chemicals that interfere with hormone function. Food packaging materials, such as plastic containers and can linings, may leach chemicals like bisphenol A (BPA) into food. Household detergents frequently contain surfactants and preservatives with endocrine-disrupting properties. Plastic bottles and containers used for storing food and beverages commonly include BPA and phthalates. Even children’s toys may contain phthalates, which have been shown to disrupt hormonal development.1

Xenoestrogens are a type of EDC that mimics estrogen and can interfere with endocrine processes. Xenoestrogens can be found in everyday items such as phthalates, polychlorinated biphenyls, and parabens. Exposure to xenoestrogens can lead to many health issues, including breast, prostate, and uterus cancer, as well as reproductive and immune system dysfunction.

The endocrine system regulates the body’s development, growth, reproduction, metabolism, immunity, and behavior through the production of hormones. EDCs interfere with this precisely coordinated system, resulting in potentially life-long health effects that can even have consequences for the next generation by genomic involvement or epigenetic mechanisms.2,3

These chemicals are also absorbed through dermal exposure; therefore, knowledge of these is especially relevant in dermatoses with impaired skin barriers such as atopic dermatitis, acne, or rosacea4 in which systemic absorption of ingredients in topical creams and moisturizers is likely to be enhanced.

WHAT ARE ENDOCRINE DISRUPTORS?

An endocrine disruptor is an exogenous chemical or mixture of chemicals that can interfere with any aspect of hormone action. Examples include phthalates, parabens, triclosan, BPA, and dioxins, to name a few.1

Of the hundreds of known EDCs, a subset is present in personal care products like moisturizers, making them relevant to dermatologists.5 Since the skin is the largest organ of the body, systemic absorption through it is significant, especially when the skin is inflamed. Therefore, we are focusing on topical products containing EDCs, such as moisturizers, as they pose a greater risk of absorption and potential hormonal disruption.

There is no safe dose of EDCs and they act in very small concentrations. Invariably individuals are usually not exposed to a single type of EDC but to a mixture of EDCs.2

MECHANISM OF ACTION OF EDCS

EDCs mainly produce adverse effects by disrupting the functioning of the endocrine system through the following mechanisms [Figure 1]:6,7

Mechanism of disruption of endocrine system by endocrine-disrupting chemicals. EDC: Endocrine-disrupting chemicals.
Figure 1:
Mechanism of disruption of endocrine system by endocrine-disrupting chemicals. EDC: Endocrine-disrupting chemicals.

  1. Binding to a hormone receptor leading to activation or inhibition of its signaling pathway

  2. Interactions with components of hormone signaling pathway downstream of a receptor

  3. Stimulation or Inhibition of an endogenous hormone biosynthesis

  4. Binding to circulating hormone-binding protein

  5. Stimulation or inhibition of hormone-binding protein synthesis or degradation

  6. Stimulation or inhibition of hormone receptor expression.

MAIN CHARACTERISTICS OF EXPOSURE TO EDC

The main characteristics of exposure to EDCs are as follows8

  • No Safe Dose: EDCs can have effects even at very low concentrations, and because they interact with endogenous hormones, it is challenging to define a threshold level below which they do not cause harm.

  • Vulnerable Periods: Exposure during critical stages of development – such as pregnancy, lactation, and puberty – can lead to long-lasting damage that affects the individuals throughout their life and may be passed onto future generations.

  • Non-Linear Dose-Response: The relationship between the dose of EDCs and the resulting adverse effects is not linear, meaning the response does not necessarily increase proportionally with the dose.

  • Mixture Exposure: Individuals are typically exposed to a combination of EDCs rather than a single chemical. The interactions among these chemicals – whether synergistic, additive, or antagonistic – make it difficult to predict their overall effects, often referred to as the “cocktail effect.”

  • Transgenerational Effects: The effects of EDC exposure can extend beyond the exposed individual, impacting future generations through genomic or epigenetic mechanisms. Establishing a clear causal link is complicated by the long latency periods between exposure and observable effects.

EFFECTS OF EDCS ON VARIOUS BODY ORGANS

EDCs and the female reproductive system

EDCs, such as parabens, phthalates, or triclosan, interfere with the female reproductive system by altering estrogen levels (either increasing or decreasing the levels).

This leads to disturbance in the hypothalamic-pituitary-gonadal axis, and therefore, these chemicals have been linked with impaired folliculogenesis, irregular cycles, delayed fertility or infertility, polycystic ovarian syndrome, and precocious/delayed puberty.9,10

EDCs and male reproductive system

Androgens are the main hormones required for the masculinization of genitalia during the development of the male reproductive system in utero.6 The testicular dysgenesis syndrome theory postulates that prenatal exposure to EDCs impairs the proliferation and development of fetal Leydig cells, leading to lifelong reduced production of testosterone.11

This can lead to cryptorchidism, hypospadias, poor semen quality, and ultrastructural testicular abnormalities that are similar to changes associated with human testicular cancer.6,11

EDCs and cancer

There are a few studies in the literature that illustrate that developmental exposure to EDCs can alter normal patterns of tissue organization.12

Certain EDCs like parabens have been reported to have estrogenic effects and can stimulate gene expression of insulin-like growth factor-1 and epidermal growth factor, which can lead to carcinogenesis, especially in tissues sensitive to hormonal treatment – for instance, breast, ovaries, and cervix.6,13

EDCs and thyroid gland

The mechanisms by which thyroid function is affected by EDCs include:10

  1. Central regulatory mechanisms at hypothalamic and/or anterior pituitary level

  2. Mechanisms involving synthesis, transportation, bioavailability, or metabolism of T3 and T4 hormones

  3. Development of thyroid carcinoma by some EDCs.

It is to be emphasized here that in pregnant women, disruption of thyroid hormones has significant developmental effects on newborns.

EDCs as diabetogens and obesogens

A study in 200614 defined “obesogens” as xenobiotic chemicals that can disrupt the normal developmental and homeostatic controls over adipogenesis and/or energy balance.

It has been reported that exposure to certain EDCs, such as phthalates and parabens, induces weight gain, increased body mass index (BMI), and waist circumference, and also affects adipokines involved in the regulation of food intake.6,15

EDCs, especially phthalates, have also been linked with impaired glucose metabolism, insulin secretion, development of diabetes, and related metabolic disorders.9

EDCs disrupt the neurodevelopmental system and neuroendocrine system

Animal studies have demonstrated that developmental exposures to EDCs can alter the structure and function of the brain’s neuroendocrine system.6

The central neuroendocrine systems of the body serve as an interface between the brain and the endocrine systems in the rest of the body.12 This is essentially regulated by the hypothalamic-pituitary-adrenal axis and the hypothalamic-pituitary-gonadal axis.6

EDCs exert neuroendocrine actions by acting on nuclear hormone receptors that are expressed in hypothalamic or pituitary cells, thereby altering feedback effects.

EDCs also cause impairment of cognition, learning, and memory possibly by causing alteration in the levels of neuromodulators such as dopamine, norepinephrine, serotonin, and glutamate.11 In humans, epidemiological data support associations between higher exposures to EDCs with decreased Intelligence quotient (IQ), neurodevelopmental problems, and other neurocognitive outcomes.6 Summary of systemic effects of endocrine disrupting chemicals have been summarized in Table 1 and Figure 2.

Table 1: Summary of systemic effects of endocrine-disrupting chemicals.
System Description Effects
Female reproductive system EDCs such as parabens, phthalates, and triclosan alter estrogen levels and inhibit testosterone production by Leydig cells.
  • Impaired folliculogenesis

  • Irregular cycles

  • Delayed fertility/infertility

  • Polycystic ovarian syndrome

  • Precocious/delayed puberty

Male reproductive system Prenatal exposure to EDCs disrupts Leydig cell development, reducing testosterone production.
  • Cryptorchidism

  • Hypospadias

  • Poor semen quality

  • Testicular abnormalities

  • Risk of testicular cancer

Cancer EDCs, especially parabens, have estrogenic effects and stimulate insulin-like growth factor-1 and epidermal growth factor, leading to carcinogenesis in hormone-sensitive tissues.
  • Breast, ovarian, and cervical cancer

Thyroid gland EDCs affect thyroid function through central regulation, hormone synthesis, and metabolism pathways.
  • Hypothyroidism

  • Disrupted Thyroxine (T3/T4) synthesis

  • Thyroid carcinoma

  • Developmental issues in newborns

Diabetogenic and obesogenic effects EDCs such as phthalates and parabens disrupt adipogenesis and glucose metabolism.
  • Weight gain

  • Increased body mass index/waist circumference

  • Impaired glucose metabolism

  • Diabetes and metabolic disorders

Neurodevelopmental and neuroendocrine systems EDC exposure alters brain structure, neuroendocrine function, and neurotransmitter levels.
  • Impaired cognition, learning, and memory

  • Neurodevelopmental problems

  • Lower IQ

  • Neurocognitive issues

EDCs: Endocrine-disrupting chemicals

List of organs affected by endocrine-disrupting chemicals.
Figure 2:
List of organs affected by endocrine-disrupting chemicals.

EFFECT OF EDCS ADDED IN MOISTURIZERS ON HUMAN HEALTH

There are multiple EDCs commonly present in skincare products, including moisturizers available across the globe. The most common ones are described as follows:

Parabens

Parabens are commonly used in various moisturizers available in the market. Methyl-paraben, ethyl-paraben, and butyl-paraben are the most commonly used parabens in skin and hair care products to increase the shelf-life as they have antimicrobial properties.16 However, parabens have been associated with various adverse effects:

  1. Linked with carcinogenesis due to estrogenic activity13

  2. Affect sperm production due to antiandrogenic activity17

  3. In utero exposure causes altered adrenal glands and reduced cortisol synthesis

  4. Thyroid dysfunction, increased adipogenesis, and neurodevelopmental disorders.13

The Cosmetic Ingredient Review suggests concentration limits for individual parabens (up to 0.4%) and total paraben concentrations (up to 0.8%) in a single product; however, these guidelines do not consider cumulative exposure to parabens from many products used by an individual.18

Fragrances

The word “fragrance” or “parfum” in the ingredients label implies a mix of unlabeled ingredients (sometimes more than a hundred). There are many moisturizers available in the market which claim to be “unscented” or “fragrance-free.” A limit of 0.01% (100 ppm) in cosmetic products is indicative of safe use. However, when these substances are present at concentrations >0.001% in leave-on products and >0.01% in rinse-off products, they are considered fragrance allergens and necessitate individual labelling.19

“Fragrance-free” means that no fragrance material-synthetic or natural is used in the product. However, “unscented” means that the product may have substances that neutralize or mask the odor of other active ingredients.

The endocrine-disrupting adverse effects of individual fragrance constituents, namely, phthalates, paraben, glutaraldehyde, hydroperoxides, oil of turpentine, metals, nitro musks, and essential oils, among others, are being identified and the most common ones are:

  1. Aromatase upregulation, estrogen hyperproduction, and carcinogenesis, especially with benzyl salicylate and lavender-fragranced products

  2. Neuropathies (depression and autism)

  3. Neoplasm (breast cancer and prostate cancer)

  4. Endocrinopathies (gynecomastia)

  5. Organ damage (hepatotoxicity).20,21

Phthalates

Phthalates are commonly used in moisturizers to make the fragrance last longer. Usually, phthalates are included in the ingredient “perfume” so they are not mentioned on most labels. The various types of Phthalates are di-(2-ethylhexyl) phthalate, dibutyl phthalate, benzyl butyl phthalate, diisononyl phthalate, diisobutyl phthalate, di-n-pentyl phthalate, din-hexyl phthalate, and dicyclohexyl phthalate. They can interfere with the endocrine system in numerous ways:

  1. Cause increased oxidative stress and cause impaired glucose tolerance

  2. Block uptake of iodine into thyroid cells reducing synthesis of T3 and T421

  3. Activate peroxisome proliferator-activated receptor-gamma and are associated with raised BMI and waist circumference9

  4. Associated with diminished ovarian reserve, premature births, miscarriages, and developmental abnormalities.9,16

  5. Exhibit anti-androgenic activity, thus affecting sperm count and motility, may even cause DNA damage in spermatozoa.9

The European regulations limit the use of phthalates to <0.1% for phthalates (remove “for phthalates”).22

Benzophenones

Benzophenones are usually added to the moisturizers to give an added sun protection benefit. They have been shown to possess estrogenic activity, interfere with androgens and with thyroid signalling.23 When employed as a ultraviolet-filter in cosmetic products, benzophenone-3 is safe at a maximum concentration of 6% although when it is added to safeguard the product, the maximum permitted concentration is 0.5%.24 Summary of adverse effects and approved limit of endocrine disrupting chemicals in moisturizers have been summarized in Table 2.

Table 2: Adverse effects and approved limit for parabens, fragrances, phthalates, and benzophenones.
Category Description Approved safe limit Carcinogenic effects Reproductive effects Hormonal effects Other effects
Parabens Commonly used preservatives in moisturizers with antimicrobial properties (e.g., methyl-paraben, ethyl-paraben, butyl-paraben). Individual parabens: 0.4% Total parabens: 0.8% Carcinogenesis due to estrogenic activity. Reduced sperm production. In utero adrenal effects. Thyroid dysfunction, obesity. Neurodevelopmental issues.
Fragrances The term “fragrance” or “parfum” includes a mix of unlisted ingredients; “unscented” products may still contain certain ingredients to mask odors. Allergens:
Leave-on: 0.001%
Rinse-off: 0.01%
Estrogen-related cancers (breast, prostate). Gynecomastia. Estrogen overproduction Neurological issues (depression, autism). Liver damage.
Phthalates Used to extend fragrance longevity; often hidden under the label “perfume.” <0.1% Reduces ovarian reserve, miscarriages, and birth defects.
Lowers sperm count and motility.
Reduces thyroid hormone production. Increases body mass index. Oxidative stress and impaired glucose tolerance.
Benzophenones Added to moisturizers for sun protection benefits. Benzophenone-3: Max 6% (ultraviolet-filter) Max 0.5% (product preservative) Estrogenic activity.
Disrupts androgen and thyroid signaling.

EDCS IN SPECIAL GROUPS

  1. Children-Endocrine disruptors may have different effects in developing fetus or in infantses as compared to adults. It is important to understand that infancy, childhood, and puberty are critical periods of development during which developing systems are “particularly sensitive to hormonal or other disruptions” for many reasons:

    1. Organ development continues through this period

    2. Infants’ immune systems is immature; hence, they are incapable of detoxifying and eliminating toxic chemicals

    3. Infants and young children have thinner skin than adults; therefore, chemicals are more easily absorbed.25

  2. Pregnancy-Exposure to EDCs during pregnancy has been associated with the onset of severe gestational conditions such as preeclampsia, fetal growth restriction and gestational diabetes in the mother, and reproductive tract anomalies in the fetus.26,27

    High levels of estrogen exposure in utero have been linked with several male reproductive tract abnormalities, including cryptorchidism, hypospadias, impaired spermatogenesis, and testicular tumors. Moreover, many research studies strongly indicate that the placenta is not such an effective barrier against EDCs and that pregnant women’s exposure was associated with EDCs’ entrance in the fetal circulation. The developing fetus might be more sensitive to EDCs than the adult. Thus, EDCs could negatively impact fetal and placental health by interfering with the embryonic developing epigenome, thus establishing disease paths into adulthood.26

  3. Lactation-Exposure to EDCs in postnatal life through breast milk may interfere with germ cell development.27

PURPOSE AND IMPORTANCE OF PRESERVATION

Cosmetic products, including moisturizers, makeup, shampoos, and serums, often contain water-based ingredients that create an ideal environment for microbial growth. Without proper preservation, these products can degrade, leading to changes in appearance, texture, and safety. Preservatives play a key role in maintaining the stability, effectiveness, and longevity of cosmetic formulations. Parabens offer broad-spectrum protection against bacteria and molds with excellent stability, while phenoxyethanol is a cost-effective option effective across a wide pH range. Benzyl alcohol is skin-friendly and compatible with various ingredients, targeting bacteria and yeasts. Formaldehyde releasers provide long-lasting preservation, making them suitable for natural formulations. Sorbic acid and benzoic acid are commonly used to combat molds, yeasts, and certain bacteria, often in combination with other preservatives. Ethylhexylglycerin enhances antimicrobial activity while also conditioning the skin, whereas caprylyl glycol offers hydration along with antimicrobial benefits. Sodium benzoate and potassium sorbate are widely used in water-based formulations to extend shelf life. Natural extracts and botanical blends, such as rosemary or grapefruit seed extracts, serve as eco-friendly alternatives, often combined with other preservatives for enhanced efficacy. Selecting the appropriate preservative depends on formulation type, pH compatibility, and product longevity requirements.

Potential Risks of Inadequate Preservation

  • Product Spoilage: Bacterial and fungal activity can break down cosmetic ingredients, resulting in discoloration, unpleasant odors, or an altered texture

  • Contamination Risks: Microbial contamination can introduce harmful toxins or allergens, potentially causing skin irritations, infections, or other health concerns

  • Reduced Effectiveness: Microorganisms may degrade active ingredients, diminishing the product’s intended benefits

  • Shortened Shelf Life: Without preservatives, microbial growth accelerates spoilage, significantly reducing the product’s usability over time.

ROLE OF FORMULATION FACTORS IN EDC ABSORPTION

The absorption of EDCs through the skin is significantly influenced by various formulation factors in cosmetic and personal care products. These factors determine the extent to which EDCs penetrate the skin barrier and enter systemic circulation.

  • Vehicle Composition: The type of solvent or base used in a formulation affects the solubility and penetration of EDCs. Lipophilic solvents (e.g., oils and alcohols) can enhance absorption by disrupting the skin barrier, whereas hydrophilic bases may limit penetration.28

  • Emulsifiers and Surfactants: These compounds, commonly found in creams and lotions, can alter skin permeability by interacting with lipids in the stratum corneum, potentially facilitating EDC absorption.28

  • Molecular Size and Lipophilicity: EDCs with low-molecular-weight and high lipophilicity tend to penetrate the skin more easily, particularly when incorporated into formulations that promote their solubility.29,30

  • pH of the Formulation: The skin has a slightly acidic pH (4.5–5.5), and formulations with extreme pH values may compromise the integrity of the skin barrier, enhancing the penetration of EDCs.29,30

  • Occlusion and Hydration: Occlusive formulations, such as ointments or thick creams, increase skin hydration and may enhance the absorption of EDCs by disrupting the natural barrier function.29,30

THE IMPACT OF CUMULATIVE EXPOSURE TO EDCS: A PERSISTENT HEALTH RISK

Many EDCs are persistent in the environment and bioaccumulate in living organisms, meaning prolonged exposure could lead to higher internal concentrations over time. Even after their prohibition in some regions, these chemicals continue to affect populations, highlighting the ongoing risk of long-term exposure. In addition, EDCs can cross the placenta and be transmitted through breast milk, impacting fetal and neonatal development, with a long latency period between exposure and disease manifestation. Their mechanisms of action, including interference with hormone synthesis, receptor binding, metabolism, and epigenetic modifications, suggest that cumulative exposure may lead to lasting effects. Chronic exposure has been correlated with metabolic syndrome, obesity, and hormone-related cancers such as breast and prostate cancer, conditions that typically develop over time. While a precise dose-effect relationship is unclear, the persistence, bioaccumulation, and long-latency effects of EDCs strongly imply that prolonged and repeated exposure increases the risk of adverse health outcomes.31

LABELING STANDARDS IN INDIA

As per Chapter VI of the Cosmetics Rules, 2020, Section 34(7) states that all cosmetics must list ingredients present in a concentration of more than 1% in descending order of weight or volume, followed by those in a concentration of 1% or less in any order. The list must be preceded by the word “INGREDIENTS.” However, this requirement does not apply to packages smaller than 60 mL for liquids and 30 g for solids or semi-solids.

In addition, Section 34(8) mandates compliance with labeling requirements as per the Bureau of Indian Standards (BIS) for cosmetics listed in the Ninth Schedule.

Thus, while most cosmetic products are required to display a full ingredient list, small-sized packs are exempt, and compliance with BIS standards is necessary.

PARABEN-FREE AND FRAGRANCE-FREE LABELS

Paraben- and fragrance-free labeling has gained popularity among consumers seeking safer skincare options; however, the absence of these ingredients does not necessarily ensure absolute safety. Many alternative preservatives, such as methylisothiazolinone, have been linked to increased cases of allergic contact dermatitis, raising concerns about their widespread use.32 Similarly, “fragrance-free” does not always mean the complete absence of scent-related compounds, as some products may contain botanical extracts or masking agents that can still cause sensitization.33 Furthermore, certain preservative alternatives used in cosmetics, especially in spray formulations, may pose potential inhalation risks.34 Therefore, while such labels may appeal to consumers, an evidence-based approach to ingredient selection is crucial. Our manuscript emphasizes the importance of evaluating product safety based on scientific data rather than marketing claims, ensuring that dermatologists and consumers are well-informed about potential risks.

CONCLUSION

EDCs are environmental pollutants that interfere with the hormonal systems of humans and wildlife. These chemicals, found in pesticides, plastics, personal care products, and industrial waste, enter the environment through agricultural runoff, improper waste disposal, and industrial emissions. EDCs such as BPA, phthalates, and parabens can mimic or block natural hormones, leading to developmental, reproductive, neurological, and immune system disorders. They persist in soil, air, and water, accumulating in the food chain and posing long-term risks to ecosystems and public health. Addressing EDC pollution requires stricter regulations, sustainable practices, and public awareness. At present, much of the available data pertaining to the side effects of EDCs exists in animal studies. Generating human data on EDC exposure requires large-scale epidemiological studies and biomonitoring programs that assess exposure levels, biomarkers, and health outcomes over time. Longitudinal studies tracking individuals with varying levels of exposure can help determine cumulative effects and latency periods. Future research should focus on standardized exposure assessment methods, integrating real-world exposure data with clinical findings to establish clearer causal relationships in dermatology.

While it may not be possible to eliminate these toxic chemicals from our day-to-day lives, it is prudent that we minimize their exposure. This holds even more importance for individuals in special age groups and also for patients with impaired barrier function, for instance, dermatitis, rosacea, or acne, where chances of dermal exposure are higher. Therefore, it should be ensured that these patients are prescribed moisturizers that are devoid of harmful EDCs such as parabens, fragrances, and phthalates.

With growing awareness and regulatory scrutiny surrounding EDCs, integrating their study into the medical curriculum is essential for equipping healthcare professionals with the knowledge needed to assess and mitigate related health risks. Given the potential links between EDC exposure and various systemic and dermatological conditions, medical education should include foundational topics such as sources of exposure, mechanisms of endocrine disruption, bioaccumulation, and long-term health effects.

Authors contributions:

All three authors (Shikha Gupta, Sanjeev Gupta, Aditi Dabhra) have equally contributed in gathering the data for this publication and take the responsibility of genuinity.

Ethical approval:

Institutional Review Board approval is not required.

Declaration of patient consent:

Patient’s consent was not required as there are no patients in this study.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. , , , , , , et al. Endocrine-disrupting chemicals and public health protection: A statement of principles from the endocrine society. Endocrinology. 2012;153:4097-110.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , . Combined toxicity of endocrine-disrupting chemicals: A review. Ecotoxicol Environ Saf. 2021;215:112136.
    [CrossRef] [PubMed] [Google Scholar]
  3. . What is an endocrine disruptor? C R Biol. 2017;340:403-5.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , . Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc. 2019;40:84-92.
    [CrossRef] [PubMed] [Google Scholar]
  5. , . Endocrine-disrupting chemicals in cosmetics. JAMA Dermatol. 2020;156:603-4.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , , , , et al. EDC-2: The endocrine society's second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36:E1-150.
    [CrossRef] [PubMed] [Google Scholar]
  7. , . Comparative overview of the mechanisms of action of hormones and endocrine disruptor compounds. Toxics. 2019;7:5.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , . Endocrine disrupting chemicals in cosmetics and personal care products and risk of endometriosis. London: IntechOpen; 2020
    [CrossRef] [Google Scholar]
  9. , , , . Endocrine disrupting chemicals: Exposure, effects on human health, mechanism of action, models for testing and strategies for prevention. Rev Endocr Metab Disord. 2020;21:127-47.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , , . Nonpersistent endocrine disrupting chemicals and reproductive health of women. Obstet Gynecol Sci. 2020;63:1-12.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , , . Endocrine-disrupting chemicals: Implications for human health. Lancet Diabetes Endocrinol. 2020;8:703-18.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , , , , , et al. Endocrine-disrupting chemicals: An endocrine society scientific statement. Endocr Rev. 2009;30:293-342.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , , . Parabens and their effects on the endocrine system. Mol Cell Endocrinol. 2018;474:238-51.
    [CrossRef] [PubMed] [Google Scholar]
  14. , . Environmental obesogens: Organotins and endocrine disruption via nuclear receptor signaling. Endocrinology. 2006;147:S50-5.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , . Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect. 2007;115:876-82.
    [CrossRef] [PubMed] [Google Scholar]
  16. , . Female exposure to endocrine disrupting chemicals and fecundity: A review. Curr Opin Obstet Gynecol. 2017;29:202-11.
    [CrossRef] [PubMed] [Google Scholar]
  17. . Effects of butyl paraben on the male reproductive system in mice. Arch Toxicol. 2002;76:423-9.
    [CrossRef] [PubMed] [Google Scholar]
  18. . Final amended report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, and benzylparaben as used in cosmetic products. Int J Toxicol. 2008;27:1-82.
    [CrossRef] [PubMed] [Google Scholar]
  19. . Regulation (EU) 2023/1545 of the European parliament and of the council of 12 July 2023 on cosmetic products. . EUR-lex. Available from: https://eur-lex.europa.eu/eli/reg/2023/1545/oj [Last accessed on 2024 Dec 23]
    [Google Scholar]
  20. , , , , , , et al. Lavender products associated with premature thelarche and prepubertal gynecomastia: Case reports and endocrine-disrupting chemical activities. J Clin Endocrinol Metab. 2019;104:5393-405.
    [CrossRef] [PubMed] [Google Scholar]
  21. . Fragrance compounds: The wolves in sheep's clothings. Med Hypotheses. 2017;102:106-11.
    [CrossRef] [PubMed] [Google Scholar]
  22. Regulation (EC) No 1907/2006 - registration, evaluation, authorisation and restriction of chemicals (REACH) (N.D.) Safety and health at work EU-OSHA. Available from: https://osha.europa.eu/en/legislation/directives/regulation-ec-no-1907-2006-of-the-european-parliament-and-of-the-council [Last accessed on 2025 Jan 07]
    [Google Scholar]
  23. , , , . Analytical methods for the determination of endocrine disrupting chemicals in cosmetics and personal care products: A review. Talanta. 2021;234:122642.
    [CrossRef] [PubMed] [Google Scholar]
  24. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast) Official Journal of the European Union 2009. Vol 342:59-209. Available from: http://data.europa.eu/eli/reg/2009/1223/oj [Last accessed on 2025 Jan 07]
    [Google Scholar]
  25. , . Exposures to endocrine disrupting chemicals in consumer products-a guide for pediatricians. Curr Probl Pediatr Adolesc Health Care. 2017;47:107-18.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , , . Fetal-maternal exposure to endocrine disruptors: Correlation with diet intake and pregnancy outcomes. Nutrients. 2020;12:1744.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , . Maternal use of personal care products during pregnancy and risk of testicular germ cell tumors in sons. Environ Res. 2018;164:109-13.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , . The effects of emulsifiers and emulsion formulation types on dermal and transdermal drug delivery In: , , eds. Percutaneous penetration Enhancers chemical methods in penetration enhancement. Berlin, Heidelberg: Springer; . p. :223-41.
    [CrossRef] [Google Scholar]
  29. . Skin penetration enhancers. Int J Pharm. 2013;447:12-21.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , . The role of excipients in promoting topical and transdermal delivery: Current limitations and future perspectives. Front Drug Deliv. 2022;2:1049848.
    [CrossRef] [Google Scholar]
  31. , . Combined effects of different endocrine-disrupting chemicals (EDCs) on prostate gland. Int J Environ Res Public Health. 2021;18:9772.
    [CrossRef] [PubMed] [Google Scholar]
  32. , . Methylisothiazolinone. Dermatitis. 2013;24:2-6.
    [CrossRef] [PubMed] [Google Scholar]
  33. , , . Fragrance and its allergic effects: What the dermatologist should know. Eur J Dermatol. 2019;29:103-13.
    [Google Scholar]
  34. , , , , , , et al. Special aspects of cosmetic spray safety evaluations: Principles on inhalation risk assessment. Toxicol Lett. 2011;205:97-104.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections